Claritev (CTEV) Investor Day 2026 summary

Strategic vision and growth trajectory

• Pursuing a multi-year transformation focused on transparency, affordability, and access, with a unique network and data-driven solutions supporting the healthcare lifecycle.

• Vision 2030 strategy emphasizes long-term growth, innovation, and technology investment, with a shift from stabilization to aggressive expansion and diversification, including five new market verticals and international expansion.

• Diversification efforts have reduced reliance on top ten clients by 10%-12% over 18 months, with 30 new/re-activated logos and entry into new verticals.

• Investing $20M–$35M annually in technology modernization through 2028, prioritizing organic investments, debt paydown, and value-creating M&A to fuel Vision 2030.

• Commitment to delivering on promises, with a $100 million sales target for the team and a robust product roadmap in place.

Product innovation and technology modernization

• Major investments in Oracle Cloud and AI infrastructure enable scalable, efficient operations and product development, with core platforms migrated to Oracle Cloud.

• AI and machine learning are embedded across offerings, driving automation, predictive analytics, and operational leverage, with over 50 AI models in production.

• Roadmap for 2026 includes 30+ new features and 18+ new solutions across claims intelligence, network, payment & revenue integrity, and data & analytics.

• Proprietary tools like BenInsights and CompleteVue provide actionable analytics for employers and providers, enabling proactive cost management and negotiation.

• Payment and revenue integrity solutions leverage automation and expert review to identify and prevent improper payments, generating nearly $2 billion in annual savings for clients.

Financial performance and guidance

• Returned to revenue growth with 6.7% year-over-year increase in Q4, and 4% growth for 2025, despite client attrition.

• FY 2026 revenue guidance set at $980M–$1B, with adjusted EBITDA of $605M–$615M and capital spend of $160M–$170M.

• Projecting 4–6% revenue CAGR through 2028, with adjusted EBITDA margin of 61–62% and mid-single-digit growth excluding one-time items.

• Vision 2030 targets at least $1.3 billion revenue and $800 million EBITDA, with free cash flow yield expected to triple post-2028 as tech modernization completes.

• Levered free cash flow expected to rise from $0–$10M in 2026 to over $225M by 2030, with net leverage declining from 7.5x to ~5.0x.